Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4
Authors
Keywords
-
Journal
Cancer Biomarkers
Volume 21, Issue 2, Pages 323-334
Publisher
IOS Press
Online
2017-11-05
DOI
10.3233/cbm-170464
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer
- (2018) Jonathan R. Brody et al. CANCER BIOLOGY & THERAPY
- Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria
- (2017) Michela Visani et al. JOURNAL OF NEURO-ONCOLOGY
- Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates
- (2016) Dario de Biase et al. JOURNAL OF CLINICAL PATHOLOGY
- Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma
- (2016) Filippo Lococo et al. Journal of Thoracic Oncology
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- COSMIC: somatic cancer genetics at high-resolution
- (2016) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Pancreatectomy Predicts Improved Survival for Pancreatic Adenocarcinoma
- (2015) Bradley D. McDowell et al. ANNALS OF SURGERY
- Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis
- (2015) M. Dal Molin et al. CLINICAL CANCER RESEARCH
- p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells
- (2015) J M Bailey et al. ONCOGENE
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Genomic alterations in pancreatic cancer and their relevance to therapy
- (2015) Erina Takai et al. World Journal of Gastrointestinal Oncology
- Oncogenic KRAS signalling in pancreatic cancer
- (2014) S Eser et al. BRITISH JOURNAL OF CANCER
- Next Generation Sequencing Improves the Accuracy of KRAS Mutation Analysis in Endoscopic Ultrasound Fine Needle Aspiration Pancreatic Lesions
- (2014) Dario de Biase et al. PLoS One
- Novel KRAS Gene Mutations in Sporadic Colorectal Cancer
- (2014) Walid M. Naser et al. PLoS One
- Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A/p16, TP53, and SMAD4/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer
- (2013) Minoru Oshima et al. ANNALS OF SURGERY
- Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
- (2013) Robert L. Fine et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- IDH1 and IDH2 Mutations in Gliomas
- (2013) Adam L. Cohen et al. Current Neurology and Neuroscience Reports
- Roles for KRAS in Pancreatic Tumor Development and Progression
- (2013) Marina Pasca di Magliano et al. GASTROENTEROLOGY
- Multiple KRAS Mutations in Pancreatic Adenocarcinoma
- (2013) Michela Visani et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Conceptual Framework for Cutting the Pancreatic Cancer Fuel Supply
- (2012) A. Le et al. CLINICAL CANCER RESEARCH
- Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma
- (2012) Luigi Laghi et al. PLoS One
- Pancreatic ductal adenocarcinoma: Long-term survival does not equal cure
- (2012) Cristina R. Ferrone et al. SURGERY
- T[20] repeat in the 3′-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer
- (2011) Luca Morandi et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
- (2011) D. R. Borger et al. ONCOLOGIST
- Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference
- (2010) Luca Morandi et al. BMC CANCER
- Hereditary Pancreatic Cancer
- (2010) Shilpa Grover et al. GASTROENTEROLOGY
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
- (2009) A. Blackford et al. CLINICAL CANCER RESEARCH
- Risk of Pancreatic Cancer in Families With Lynch Syndrome
- (2009) Fay Kastrinos JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Differences and evolution of the methods for the assessment of microsatellite instability
- (2008) L Laghi et al. ONCOGENE
- Long-Term Survival (5-20 Years) After Pancreatectomy for Pancreatic Ductal Adenocarcinoma
- (2008) Mustapha Adham et al. PANCREAS
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started